2014. Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 31, 3 (Oct. 2014), 198–205.